Peer-reviewed research

Peer-reviewed research refers to the process where academic work is evaluated by experts in the same field before publication to ensure rigor, validity, and reliability. This mechanism is critical for verifying research findings. According to the San Francisco Declaration on Research Assessment (DORA), traditional metrics like Journal Impact Factor are insufficient for assessing research quality. In a corporate risk management context, this means that any technical claim or innovation must be validated through a structured review process before being used as a basis for strategic decisions. Without this, companies risk investing in flawed methodologies or unreplicable results, which can lead to significant financial and reputational damage. This is especially critical in highly regulated sectors like biotechnology, fintech, and AI development, where the cost of error is extremely high.

Implementation involves three key steps: First, establish a Technical Evaluation Committee comprising both internal subject matter experts and external consultants to ensure objectivity. Second, create a Research Verification Protocol that-—similar to ISO 56001 innovation management principles—standardizes the criteria for evaluating external research-—including sample size, control groups, and statistical significance. Third, integrate these findings into the Enterprise Risk Management (ERM) framework, assigning a risk-adjusted value to each research-based claim. For instance, a company considering a new AI-driven-—based on a pre-print paper—should assign a high risk-adjusted-—and be closely monitored. A real-world application is seen in pharmaceutical companies, where RTO (Research-to-Operations)-—processes require rigorous validation of preclinical data before moving to clinical trials, reducing the risk of late-stage failure by up to 40%.

Taiwan enterprises typically face three challenges: 1. Resource Constraints—many SMEs lack the budget for external experts. The solution is to adopt a tiered approach, only performing deep-dive reviews for high-impact technologies. 2. Lack of In-house Expertise—technical teams often lack the statistical and methodological skills required for rigorous review. This can be mitigated by partnering with academic institutions or specialized consulting firms. 3. Cultural Resistance—decision-making often relies on seniority rather than evidence-based analysis. To overcome this, companies must institutionalize the research-based decision-making process, making it a requirement for all RTO-—related capital expenditures. The priority should be to first implement this in R&D-—intensive departments before scaling across the organization, with a target of 100% critical technology assessment coverage within 12 months.

Winners Consulting Services Co., Ltd. specializes in Peer-reviewed research-—related risk assessment for Taiwan enterprises, delivering compliant management systems within 90 days. We have assisted over 100 companies in establishing technical risk-—based decision-making frameworks. Apply for a free mechanism diagnosis: https://winners.com.tw/contact